{"name": "Oncolix",
 "permalink": "oncolix",
 "crunchbase_url": "http://www.crunchbase.com/company/oncolix",
 "homepage_url": "http://www.oncolixbio.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "mredman@oncolixbio.com",
 "phone_number": "281 402-3167",
 "description": "",
 "created_at": "Mon May 27 12:44:24 UTC 2013",
 "updated_at": "Mon May 27 12:53:47 UTC 2013",
 "overview": "\u003Cp\u003EOncolix is a clinical-stage biotechnology company that is focused on cancer. The company is currently conducting a Phase I clinical trial for the indication of ovarian cancer. The drug, Prolanta, is a prolactin receptor antagonist. The mechanism of action is autophagocytosis or autophagy.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0026/7534/267534v1-max-150x150.png"],
     [[250,
       74],
      "assets/images/resized/0026/7534/267534v1-max-250x250.png"],
     [[251,
       75],
      "assets/images/resized/0026/7534/267534v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO \u0026 Board Member",
    "person":
     {"first_name": "Michael",
      "last_name": "T. Redman",
      "permalink": "michael-t-redman",
      "image": null}},
   {"is_past": false,
    "title": "Chief Regulatory Officer",
    "person":
     {"first_name": "William",
      "last_name": "E. Gannon",
      "permalink": "william-e-gannon",
      "image": null}},
   {"is_past": false,
    "title": "SVP of Finance and Administration",
    "person":
     {"first_name": "Donald",
      "last_name": "Payne",
      "permalink": "donald-payne",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$3.95M",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1574061/000157406113000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 50000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 8,
    "funded_day": 17,
    "investments":
     []},
   {"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1574061/000157406113000002/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 10,
    "funded_day": 10,
    "investments":
     []},
   {"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1574061/000157406113000003/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 2400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 4,
    "funded_day": 24,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "14405 WALTERS ROAD, SUITE 780",
    "address2": "",
    "zip_code": "77014",
    "city": "HOUSTON",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        106],
       "assets/images/resized/0026/7533/267533v1-max-150x150.png"],
      [[250,
        176],
       "assets/images/resized/0026/7533/267533v1-max-250x250.png"],
      [[450,
        318],
       "assets/images/resized/0026/7533/267533v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}